DGAT1 and obesity due to melanocortin 4 receptor deficiency: In humans, in addition to the clinical interest in the DGAT1 enzyme as a target for obesity treatment [5–7], studies have found related roles for this enzyme in many human disorders, such diabetes [8], nonalcoholic steatohepatitis [9] and insulin resistance [10].